大和上调对新秀丽今年至2027年每股盈利预测7%至16%，基于产品组合变化带来更坚韧的毛利率，以及市场开支缓慢上升。在潜在展开的新的收入上升周期，以及潜在美国上市带来更多全球投资者下，认为明年预测市盈率13倍的目标价为真实可达到的目标。该行上调对新秀丽目标价，由16港元上调至25港元，投资评级由“持有”上调至“买入”。
大和上调对新秀丽今年至2027年每股盈利预测7%至16%，基于产品组合变化带来更坚韧的毛利率，以及市场开支缓慢上升。在潜在展开的新的收入上升周期，以及潜在美国上市带来更多全球投资者下，认为明年预测市盈率13倍的目标价为真实可达到的目标。该行上调对新秀丽目标价，由16港元上调至25港元，投资评级由“持有”上调至“买入”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.